Roche and Causaly Webinar

Roche and Causaly Webinar: AI for smarter portfolio management

Pharmaceutical research is inherently risky and failed or discontinued projects are an inevitable part of the R&D process. A key challenge is that competitive information and the biological validation necessary to decide on target selection and clinical development is often unavailable in a timely or holistic manner.

0 min read
Written by
Maria Tella
  • Categories
  • Causaly
Receive the latest newsletter directly to your inbox

More on Causaly